Helle F, Skogstrand T, Schwartz IF, Schwartz D, Iversen BM, Palm F, Hultström M. Nitric oxide in afferent arterioles after uninephrectomy depends on extracellular L-arginine. Am J Physiol Renal Physiol 304: F1088 -F1098, 2013. First published February 13, 2013 doi:10.1152/ajprenal.00665.2011.-Uninephrectomy (UNX) causes hyperperfusion of the contralateral remaining kidney via increased nitric oxide (NO) synthesis. Although the exact mechanism remains largely unknown, we hypothesize that this would be localized to the afferent arteriole and that it depends on cellular uptake of L-arginine. The experiments were performed in rats 2 days (early) or 6 wk (late) after UNX and compared with controls (Sham) to study acute and chronic effects on NO metabolism. Renal blood flow was increased after UNX (21 Ϯ 2 ml·min Ϫ1 ·kg Ϫ1 in sham, 30 Ϯ 3 in early, and 26 Ϯ 1 in late, P Ͻ 0.05). NO inhibition with N -nitro-L-arginine methyl ester hydrochloride (L-NAME) caused a greater increase in renal vascular resistance in early UNX compared with Sham and late UNX (138 Ϯ 24 vs. 88 Ϯ 10, and 84 Ϯ 7%, P Ͻ 0.01). The lower limit of autoregulation was increased both in early and late UNX compared with Sham (P Ͻ 0.05). L-NAME did not affect the ANG II-induced contraction of isolated afferent arterioles (AA) from Sham. AA from early UNX displayed a more pronounced contraction in response to L-NAME (Ϫ57 Ϯ 7 vs. Ϫ16 Ϯ 7%, P Ͻ 0.05) and in the absence of L-arginine (Ϫ41 Ϯ 4%, P Ͻ 0.05) compared with both late UNX and Sham. mRNA expression of endothelial NO synthase was reduced, whereas protein expression was unchanged. Cationic amino acid transporter-1 and -2 mRNA was increased, while protein was unaffected in isolated preglomerular resistance vessels. In conclusion, NO-dependent hyperperfusion of the remaining kidney in early UNX is associated with increased NO release from the afferent arteriole, which is highly dependent on extracellular L-arginine availability.
satory hypertrophy, which develops over the following weeks. The early increase in RBF is dependent on endothelial nitric oxide synthase (eNOS) in vivo (20, 29) , but the exact mechanism for the increased NO release remains largely unknown. Total or partial UNX occurs in different clinical situations, of which kidney removal because of cancer and donation for transplantation are the most common causes.
In two recent papers, we have reported increased NO release in isolated AA from the nonclipped kidney of renal hypertensive rats (2K1C) and from rats infused with angiotensin II (ANG II). The increased NO release was associated with elevated expression of the cationic amino acid transporters 1 (CAT1) and 2 (CAT2) (11, 13) . One of the substrates of this transporter, L-arginine, is utilized by eNOS in the production of NO. Even though intracellular concentrations of L-arginine are higher than the K m of eNOS, the transport of extracellular L-arginine into the cell is known to regulate NO synthesis (26) and is commonly referred to as the "arginine paradox" (reviewed in Ref. 26) . Therefore, regulation of cellular L-arginine uptake has the potential to affect renal vascular resistance (RVR).
In rats suffering from essential hypertension, UNX results in proteinuria and compromised single-nephron GFR 22-32 wk after kidney removal (1) . On the other hand, UNX can also confer vascular protection in renal injury caused by Shiga toxin (3), glycerol (27) , or acute ischemic renal failure (6) . Thus a better understanding of the adaptive responses to UNX can unveil important protective mechanisms with clinical relevance.
The aim of the present study was to determine whether and how UNX induces NO release in AA from the contralateral kidney. Experiments were performed to study the role of NO release on RBF autoregulation in vivo and ANG II-induced NO release from isolated AA after early UNX (2 days) and compared with late UNX (6 wk) and corresponding controls (Sham). We tested the role of NO in regulating RBF by using the nonspecific NOS inhibitor N -nitro-L-arginine methyl ester hydrochloride (L-NAME) and the importance of cellular L-arginine uptake by performing experiments in L-arginine-free medium. Our hypothesis was that the increased role of NO in mediating increased RBF in early UNX is manifested as increased vasoconstriction in response to NOS inhibition or L-arginine depletion together with increased gene products of CAT1 and CAT2, which are the main transporters responsible for cellular uptake of L-arginine. Furthermore, as RBF declines in late UNX, we hypothesized that these early changes become less noticeable as a function of time.
METHODS

Animals.
All experiments were performed in accordance with the National Institutes of Health Guide for the Care and Use and of Laboratory Animals and approved by the local animal research ethics representative at the University of Bergen (Bergen, Norway) and by the animal research ethics committee in Uppsala, Sweden.
The experiments used 138 male Wistar rats from Taconic (Ry, Denmark), weighing ϳ180 g at 6 wk of age when the experiments were started. The rats had free access to standard rat food and tap water. The animals were anesthetized using isoflurane (2% in 100% O 2), and the left kidney was removed through a subcostal incision. Sham surgery served as control (Sham). The animals were allowed to wake up in an infant incubator at 32°C and given 0.03 mg/kg buprenorphene. Experiments were performed 2 days (early UNX) and 6 wk (late UNX) after UNX, or in animals that underwent sham surgery (Sham). The six-week period was chosen to describe the chronic hypertrophic state in which NO dependence has been shown to be reduced (29) , in addition it mimics our previous study in 2K1C rats (11) .
RBF and autoregulation. Two days or six weeks postnephrectomy, the animals were anesthetized with isoflurane (2% in O 2) and prepared for measurement of RBF. The animals were placed on a servocontrolled heating device, and body temperature was maintained at 38°C. The femoral vein was catheterized for fluid replacement (physiological saline at 6 ml · h Ϫ1 · kg Ϫ1 ) and infusion of L-NAME. The femoral artery was used to measure mean arterial blood pressure (MAP) and renal perfusion pressure during the autoregulatory procedure. The urinary bladder was catheterized. With the rats in a left-side position, the right kidney was exposed through a subcostal incision and placed in a kidney holder. The ureter was catheterized, and the renal artery was dissected free. An ultrasound flow probe (T402-PB, Transonic, Ithaca, NY) was placed around the renal artery using a micromanipulator for stabilization. An adjustable clamp was placed around the aorta, above the renal arteries. The Transonic ultrasound probe was calibrated using a saline-perfused in situ kidney preparation, where the proximal aorta was catheterized and perfused at rates from 0 to 20 ml/min while the flow was measured through the renal artery after ligation of all other arterial branches. The effluent was collected through a renal vein catheter.
After surgery, the animals were allowed to stabilize for 20 min before the experiments were started (Fig. 1) . The renal steady-state autoregulation was measured by successive clamping of the aorta to reduce the renal perfusion pressure. After the autoregulatory procedure, the animals were injected with 1 mg L-NAME (in 0.1 ml saline) followed by a constant infusion of 6 mg · h Ϫ1 · kg Ϫ1 in the venous catheter. The effect of L-NAME was allowed to stabilize for 20 min, and the autoregulatory procedure was repeated one more time. The kidneys were removed and weighed at the end of the experiment after euthanasia.
Isolation of afferent arterioles. Renal resistance vessels were isolated using agarose infusion, enzyme digestion technique as described earlier (12) with some modifications. In short, rats were anesthetized with pentobarbital sodium (50 -70 mg/kg). The abdominal aorta was freed, cannulated, and the kidneys were infused with 8 ml Seaprep agarose solution (2%) in Ca 2ϩ -free medium (37°C) to create an elastic core of agarose inside the renal microvessels. About 100-m-thick slices were cut from the cortex of the kidney with a Thomas slicer (Thomas Scientific, Swedesboro, NJ) and incubated at 37°C for 1 h in calcium-free medium containing 5 g collagenase (C5138, 246 U/ml, Sigma) and 5 g protease (P3417, 0.5 U/ml, Sigma). Afferent vascular fragments were fastened to acid-washed coverslips in a perfusion chamber by self-adhesion. Before the experiments, Ca 2ϩ concentration in the medium was increased gradually to 2 mmol/l in three steps lasting 5 min (20, 200 , and 2,000 mol/l).
Ex vivo arteriolar diameter. Figure 2 shows a representative agar-filled AA in the relaxed state ( Fig. 2A ) and after stimulation with ANG II (Fig. 2B) . Figure 2 , C and D, show corresponding tracings of the lumen. The luminal diameter of the AA was measured from a series of images (2,576 ϫ 1,932 pixels, UltraView IIu CCD, PerkinElmer,Waltham, MA) 360 s after stimulation with different concentrations of ANG II (10 Ϫ9 , 10 Ϫ8 , and 10 Ϫ7 mol/l). The images were analyzed using DP-Soft 5.0 (Olympus, Tokyo, Japan), and the mean lumen diameter was calculated as lumen area divided by lumen length and given as absolute (Fig. 3 ) and relative diameters (Fig. 4) .
Diaminofluorescein loading and NO measurements. AA for nitric oxide (NO) measurements were loaded with 5.0 g/ml diaminofluorescein-FM diacetate (DAF-FM, Sigma, St. Louis, MO) in medium at room temperature for 1 h, typically producing a higher intensity at the inner part of the vessel wall corresponding to the endothelial layer (Fig. 5) . Thereafter, vessels were incubated for 15 min to ensure complete deesterification of the dye (DAF-FM). DAF-FM-loaded vessels for NO recordings were attached to the clean glass surface of a No. 1 coverslip mounted in a petri dish (MatTek P35G-1.5-14-C, Ashland, MA) containing 3 ml medium. Vessels were placed in the Perkin Elmer UltraView RS system. At t ϭ 0 s, 300 l medium was aspirated from the dish, and the same volume containing 10 Ϫ7 or 10
Ϫ6
mol/l ANG II was added, producing a final concentration of 10 Ϫ8 and 10 Ϫ7 mol/l, respectively. Additional experiments without L-arginine in the medium were performed to verify the importance of cellular uptake via CAT1 and CAT2. Fluorescence images were acquired as z-series stacks of confocal images displaying Ͼ510-nm fluorescence after excitation at 480 nm with 13% laser power and 2ϫ binning. The fluorescence intensity was normalized for each vessel. Figure 5 shows a representative vessel from Sham before and after stimulation in Liquid chromatography-tandem mass spectrometry. Tissue and plasma concentrations of L-arginine and asymmetric dimethylarginine (ADMA) were measured using liquid chromatography-tandem mass spectrometry (LC-MS/MS) at Bevital (Bergen, Norway). Animals were anesthetized with isoflurane, the abdomen was opened, and the abdominal aorta was freed from fat and connective tissue. Blood was collected from the abdominal aorta into 3-ml EDTA phlebotomy vials. Then, the aorta was ligated above the celiac trunk and the kidneys and liver were perfused with ice-cold PBS before perfusion with 1% iron oxide suspended in PBS as described previously. Blood samples were centrifuged, and 45 l plasma was mixed with 75 l 6% TCA with deuterated standards and 30 l of water. Kidney cortex and liver (0.1 g) was immediately homogenized in ice-cold 6% TCA with deuterated standards. The remaining kidney cortex was used to isolate renal resistance vessels as described previously (30) . These were collected in 6% TCA and homogenized directly. The homogenized samples and plasma were centrifuged, and the supernatant was delivered to Bevital for LC-MS/MS. Quantification was performed by the standard addition method, where each sample was split into two aliquots and a spiking solution or water was added to each. Spiking concentrations were determined in preliminary experiments, where assay linearity was confirmed with spiking both before homogenization and in the final supernatant.
Real-time RT-PCR. mRNA levels for eNOS, CAT1, and CAT2 were measured in preglomerular vessels isolated with an iron oxide method (30) . A three-step dilution of cDNA standard was used as a reference in all reactions. The results were expressed as the quantity of mRNA relatively to 18S ribosomal RNA in the same sample, making comparisons between the groups possible. The isolated tissue was immediately transferred to RNA-later (Qiagen, Hilden, Germany) and frozen at Ϫ20°C. Total RNA was extracted with an RNeasy minikit (Qiagen) and stored at Ϫ80°C until use. Reverse transcription was performed with an RT-core kit (Eurogentec, Seraing, Belgium) using random nonamers as primers. Quantitative PCR (qPCR) was performed on an ABI prism (ABI, Foster City, CA) using a qPCR Mastermix for SYBR Green I (Eurogentec). Primers for PCR of 18S were constructed using Primer Express software (ABI, Foster City, CA), while primers for the cationic amino acid transporters (CAT1, CAT2) and eNOS were ordered as ready-made Gene expression assays (ABI). The primers used for 18S ribosomal RNA (18S) were sense 5=-agtccctgccctttgtacaca-3= and antisense 5=-gatccgagggcctcactaaac-3=.
Western blot analysis. eNOS protein expressions were analyzed separately in rats 2 days after UNX and 6 wk after UNX (Fig. 7) . Proteins isolated from preglomerular vessels were extracted in lysis buffer and sonicated before centrifugation at 12,000 rpm for 10 min to remove cell debris and remaining iron oxide. The supernatants were stored at Ϫ80°C until further use. Protein was thawed and mixed with running buffer (1:4; Bio-Rad Laboratories, Oslo, Norway) and heated to 95°C for 15 min. Samples were run on 12.5% Tris · HCl gels with Tris/glycine/SDS buffer. The proteins were detected, after transfer to nitrocellulose membranes, with mouse anti-eNOS (1 g/ml; Zymed Laboratories; Invitrogen, Carlsbad, CA) in samples from late UNX and rabbit anti-eNOS (AB16301, 1:5,000, Chemicon International) in samples from early UNX. Horseradish peroxidase (HRP)-conjugated secondary antibodies (goat anti-mouse, 1:5,000; Santa Cruz Biotechnology, Santa Cruz, CA; goat anti-rabbit, AP132P, 1:5,000; Millipore) were detected by an ECL-camera (Kodak image station 2000; New Haven, CT). ␤-Actin was detected with mouse anti-rat ␤-actin antibody (1:10,000; Sigma) and secondary HRP-conjugated goat anti mouse antibody (1:30,000; Sigma). Isolated preglomerular vessel CAT1 protein expression was determined by immunoblotting. Tissue samples were placed in ice-cold PBS lysis buffer (pH 7.4), containing protease inhibitors (1 mM phenylmethylsulfonyl fluoride, 4.5 M leupeptin, and 5 M aprotinin, ICN Biomedicals), 0.01% Triton X-100, and 0.1% SDS, then mechanically homogenized and left on ice for 45 min. Homogenates were subsequently centrifuged (13,000 rpm for 10 min, at 40°C). Cell lysates were stored in aliquots in Ϫ70°C. A membrane fraction was obtained by adding an equal volume of lysis buffer supplemented by Tween 20 (0.25%). The protein content of each sample was determined by the method of Lowry. Equal amounts of protein (30 g) were prepared in sample buffer (2% SDS, 0.01% bromophenol blue, 25% glycerol, 0.0625 M Tris · HCl, pH 6.8, 5% mercaptoethanol), analyzed on a 7.5% SDS-PAGE gel, and transferred onto Hybond ECL nitrocellulose membranes (Amersham). Following blocking, membranes were incubated with polyclonal rabbit anti-rat CAT1 antibodies, 1:500 (synthesized by Dr. O. Leitner, Weizmann Institute, Rehovot, Israel), for 1 h at room temperature, washed, and incubated with secondary HRP-conjugated goat anti-rabbit antibody (1:10,000) in PBS-T for 1 h. Membranes were subsequently washed three times, for 5 min each, in PBS-T. Membranes were then stripped and reprobed with monoclonal anti-␤-actin antibodies as an internal control. The reactive bands corresponding to CAT1 were detected by enhanced chemiluminescence (Kodak X-OMAT AR film) and quantified by densitometry (n ϭ 4 different experiments) .
Chemicals. All chemicals were from Sigma unless otherwise stated. The media for contractility and NO studies contained (in g/l) 7.88 NaCl, 0.372 KCl, 0.123 MgSO 4, 0.264 CaCl2, 1.80 glucose, 0.358 Na2HPO4, 0.200 L-arginine, and 10% HEPES, corresponding (mmol/l) to 135 NaCl, 5.00 KCl, 1.02 MgSO4, 2.39 CaCl2, 10.0 glucose, 2.52 Na2HPO4, 1.15 L-arginine, and 10% HEPES. CaCl2 (2 mmol/l) was added to the medium after isolation of the vessels as described above. Lysis buffer for Western blotting contained 20 mmol/l Tris · HCl and 330 mmol/l sucrose, pH 7.3, supplemented with one tablet per 10 ml extracting buffer of protease inhibitor cocktail, complete EDTA-free (Roche Diagnostics). Blocking buffer for eNOS Western blotting contained Tris-buffered saline (137 mmol/l NaCl, 20 mmol/l Tris), 0.1% Tween 20, 0.2% iblock (ABI), 3.08 mmol/l NaN 3, and 10.72 mmol/l MgCl2 · 6 H2O. TCA, deuterated standards, and spiking solutions for LC-MS/MS were provided by Bevital.
Statistics. Data are presented as means Ϯ SE. With the exception of body weight and kidney weight, no difference was found between 2-day and 6-wk Sham groups. Therefore, the results are reported for the pooled controls (with the exception of body weight, kidney weight, and absolute afferent arteriolar diameter). The difference between groups was analyzed using ANOVA. The autoregulatory curves were analyzed using two-way ANOVA. The lower limit of autoregulation was identified as the final renal perfusion pressure before RBF decreased significantly below the starting perfusion. Overcompensation was defined as RBF increasing significantly when renal perfusion pressure was lowered. Data from isolated vessels were analyzed using two-way ANOVA with a nested random-effects model to account for the experimental design using multiple vessels from each animal. Student's t-tests were used for post hoc testing, and paired Student's t-tests were used to test for significant effect of the NOS inhibition when performed in the same animal. P Ͻ 0.05 was considered significant. Statistics were calculated using R 2.9.2 (28).
RESULTS
Corresponding UNX and Sham groups did not differ in body weight. The remaining kidneys in early UNX were similar to Sham, but late UNX displayed hypertrophy compared with Sham (Table 1) .
MAP under isoflurane anesthesia was not different between groups. Baseline RBF was increased in both early and late UNX. L-NAME increased MAP similarly in Sham and early UNX, while late UNX showed a slightly stronger response. At the same time, RBF decreased more in early UNX compared with Sham or late UNX. This corresponded to a larger increase in RVR in early UNX compared with any of the other groups (Table 2) .
RBF autoregulation. Autoregulatory curves were obtained in Sham (n ϭ 7), early UNX (n ϭ 7), and late UNX (n ϭ 7). UNX resulted in increased maximal RBF normalized for body weight (Fig. 1A) . A slight rightward shift of the lower limit of autoregulation occurred in UNX, which was more pronounced in early compared with late UNX (Fig. 1B) . L-NAME abolished the differences in RBF autoregulation between the different groups (Fig. 1, C and D) . The lower limit of autoregulation was increased 2 days after UNX (76 Ϯ 2 vs. 97 Ϯ 1 mmHg, P Ͻ 0.01) and partially normalized after 6 wk (91 Ϯ 2 mmHg, P Ͻ 0.05 compared with Sham and early UNX). Furthermore, the lower limit was shifted to the right by L-NAME in Sham and late UNX (Sham: 89 Ϯ 4.0 mmHg, late UNX 103 Ϯ 5 mmHg, P Ͻ 0.05), but not in early UNX (100 Ϯ 2 mmHg).
AA reactivity. Isolated AA were functionally and visually intact and devoid of connective tissue (Fig. 2) . There was no difference in baseline diameter between early UNX and matched Sham (14.6 Ϯ 0.4, n ϭ 102 vs. 14. Ϯ 0.8 m, n ϭ 71), or between late UNX and matched Sham (20.4 Ϯ 0.8, n ϭ 71 vs. 22.4 Ϯ 0.9 m, n ϭ 50). All groups showed significant contraction after stimulation with ANG II (Fig. 3, A-I , P Ͻ 0.05). Early and late UNX showed a difference between absolute diameters at 10 Ϫ7 mol/l ANG II, apparently driven by a difference in baseline diameter (Fig. 3, F and I) . Importantly, early UNX showed an interaction between pretreatment with L-NAME or L-arginine-free medium and ANG II-elicited contraction (Fig. 3E) . Looking instead at relative diameter change, ANG II-elicited contraction of AA from Sham was unaffected by NOS inhibition with L-NAME (Fig. 4) . The basal ANG II response was similar in AA from early and late UNX and Sham; NOS inhibition by L-NAME increased the contraction only in AA from early UNX (Fig. 4, B and C) . Similar to NOS inhibition, removing L-arginine from the medium also increased the ANG II contraction in early UNX (Fig. 4B) . Removing L-arginine in the medium had no effect on Sham or late UNX. NO release after ANG II stimulation. Loading with DAF-FM produced less intense fluorescence at the outer parts of the vessel, corresponding to the smooth muscle layer, and markedly more increased fluorescence at the core, corresponding to the endothelial layer (Fig. 5A) . After stimulation, the Sham AA (Fig. 5, A and B) do not respond as much as the early UNX vessel (Fig. 5, C and D) . ANG II stimulation at 10 Ϫ8 mol/l did not induce any detectable NO release in AA from any group (Fig. 6A) . However, ANG II at 10 Ϫ7 mol/l resulted in significantly faster increase in the fluorescence intensity in AA from early UNX compared with Sham and late UNX (Fig. 6B, P Ͻ  0.01) . Removal of L-arginine resulted in decreased fluorescence after ANG II stimulation (P Ͻ 0.01).
Gene and protein expression. Early UNX was associated with decreased eNOS mRNA expression, but similar eNOS protein expression compared with Sham (Fig. 7, A and B) . Late UNX had similar mRNA expression as Sham, and protein expression was not significantly different (Fig. 7, A and B) . The mRNA expressions of CAT1 and CAT2 were upregulated in early UNX, but similar to Sham in late UNX (Fig. 7, C-E) . As with eNOS, the protein expression of CAT1 was not changed between groups (Fig. 7D) .
Tissue concentration of L-arginine and ADMA. L-Arginine concentration was increased in kidney cortex of early UNX compared with Sham (Table 3 , P Ͻ 0.05). Plasma concentration was increased in early UNX and normalized in late UNX (Table 3 , P Ͻ 0.05).
DISCUSSION
The main new finding from the present study is that increased RBF in the contralateral kidney in early UNX is associated with increased L-arginine-dependent NO release from the AA endothelium. This was displayed as an increased dependency on extracellular L-arginine for both contraction buffering and NO synthesis as measured by DAF fluorescence. The increased influence of NO in mediating the increased RBF in early UNX was manifested as the increased in vivo vasoconstrictor response to L-NAME and a discrete rightward shift of the lower limit of autoregulation. The enhanced effect of L-NAME was absent in late UNX, which still displayed significantly elevated RBF, as previously reported (29) .
A compensatory hypertrophy of the remnant kidney occurred 6 wk after UNX (15) , similar to what has been reported in humans (7) . RBF increased after 2 days, long before hypertrophy; however, this demonstrated hyperperfusion and consequently vasodilation in the remnant kidney. Our findings confirm data by Sigmon et al. (29) that this whole-kidney vasodilatory response is mediated by NO and that it is inhibited by continuous L-NAME treatment (19) . There was a larger increase in MAP in late UNX, which should indicate a larger systemic NO dependence. The higher resultant MAP could induce a myogenically derived RVR increase that might mask part of an L-NAME effect. However, any such effect should be small considering the weak RVR response in late UNX.
We found in both early and late UNX a NO-dependent shift in the lower limit of autoregulation. This new information is consistent with the compensatory hyperperfusion of the remnant kidney. Interestingly, Sham overcompensated the autoregulation of the RBF after administration of L-NAME, which is in agreement with previous reports (14, 18) . Thus NOS inhibition is consistently reported to increase the efficiency of autoregulation (9, 17) . It is also evident that the maximal dilation is impaired after NOS inhibition, which was mani- fested as a higher minimal RVR and increased critical closure pressure in the present study.
The smaller baseline diameter of AA in younger rats compared with older rats was consistent with earlier findings in rats utilizing the vascular cast method (8) . Contraction of isolated AA in response to ANG II stimulation was similar to what we previously have found in agar-infused vessels (11) (12) (13) . Only AA from early UNX displayed increased contraction to ANG II after NOS inhibition, with a maximal response at ANG II of 10 Ϫ8 mol/l. This suggests that higher ANG II levels can overcome the vasodilatory effect of the induced NO release. This is different from the effects of ANG II in 2K1C, in which the effect of L-NAME was detected at significantly higher ANG II concentrations (11) . The fact that L-NAME does not increase the response to ANG II in controls is consistent with earlier experiments in agar-infused arterioles that do not have shear stress-induced NO release (11, 13) .
The DAF-FM fluorescence provides clear indications that the ANG II-induced NO release is increased in AA from early UNX. However, we find that our method is only able to detect an increase in fluorescence at the highest concentration of ANG II (10 Ϫ7 mol/l). We did not observe any increase in NO signal at lower ANG II concentrations. However, since fluorescence decreases as a function of time during the control period, due to photobleaching and leakage of dye out of the cells, it is possible that the absence of decreased fluorescence during baseline is an indication of NO constantly being produced. This was not investigated further since the objective of these experiments was to show that ANG II can induce NO release from isolated AA, which our results from using higher ANG II concentrations indeed indicate.
In the present and earlier studies, we have found ANG II-induced NO in AA from the nonclipped (11), ANG IIinfused (13) , and remnant UNX kidney. These diverse models have different renal perfusion, blood pressure, and activation of the renin-angiotensin system. Thus agonist-induced NO may be a physiological response to a wide range of cardiovascular challenges. A common denominator may be intrarenal ANG II levels, which are known to be increased in two of the models (2, 5, 21) , and has furthermore been shown to occur in subtotal nephrectomy (31) . However, the role of intrarenal ANG II in UNX remains to be elucidated. A recent study confirmed that UNX induces hyperfiltration through eNOS, and soluble guanylyl cyclase (sGC) in mice. Interestingly, both hyperfiltration and renal compensatory hypertrophy were absent in eNOSdeficient mice but were reinstated with a synthetic sGC agonist in the knockout mice (20) . The present results extend this to show that endothelial NO synthesis is vital also in the rat and visualizes this in isolated afferent arterioles. The originating signal, however, is still elusive.
L-Arginine infusion has previously been shown to lower blood pressure in rat models of both unilateral and bilateral urethral obstruction (4) . In addition, L-arginine substitution increases the bioavailable NO levels in diabetic rat kidneys (22) . These studies indicate that plasma concentration of Larginine directly affects NO release. In agreement with previous reports in other preparations (10, 11, 13, 26, 32) , the present study demonstrates for the first time that extracellular L-arginine is necessary for NO synthesis in the isolated AA from early UNX. Taken together, these findings highlight the role of cellular uptake of L-arginine for NO synthesis.
In vessels, both L-arginine and ADMA concentrations as well as eNOS protein expression were unchanged after UNX. In addition, while the mRNA expressions of both CAT1 and CAT2 Table 2 . Effect of UNX and L-NAME on blood pressure and the renal blood flow Values are means Ϯ SE. L-NAME, N -nitro-L-arginine methyl ester hydrochloride. MAP, mean arterial pressure; RBF, renal blood flow; ⌬MAP, change in mean arterial pressure after L-NAME; ⌬RBF, change in renal blood flow after L-NAME; ⌬RVR, change in renal vascular resistance after L-NAME; bw, body weight; kw, kidney weight. *Significant difference compared with sham. †Significant difference between early and late UNX. were increased, protein expression of CAT1 was not changed. Thus the mechanism behind the increased NO synthesis is still not completely understood. Interestingly, we have previously found that CAT1 and CAT2 mRNA to be increased also in the nonclipped (11) and the ANG II-infused kidney (13) . Taken together, these studies suggest a significant posttranscriptional regulation of ANG II-induced NO synthesis, as might be expected.
The intracellular concentration of L-arginine was not increased in isolated vessels from early UNX. This further strengthens the notion that cellular uptake of L-arginine is more important for NO synthesis than intracellular L-arginine concentration. The concentration of L-arginine was increased in whole-kidney cortex, which probably originated from increased uptake by the proximal tubule due to the increased filtered load. Similar to humans (16) , plasma ADMA was slightly increased in early UNX. One explanation for this could be that the kidney is important for ADMA turnover in the body.
L-NAME did not enhance the contractility of Sham AA, although NOS inhibition caused a pronounced reduction in RBF in vivo. This is likely a result of the agarose preparation of the AA used in the present study, which is devoid of shear stress, an important stimulus for NO in the in vivo setting. This is consistent with other studies that have found that L-NAME per se does not affect the diameter of the perfused AA (23) (24) (25) .
In conclusion, compensatory hyperperfusion of the remaining kidney in early UNX is NO dependent and associated with agonist-induced NO release from isolated AA. Extracellular L-arginine is required for this increase in NO release, which suggests that increased substrate availability is important in the initial phase of UNX. These data highlight the role of the AA endothelium and endothelium-derived NO as important mechanisms to compensate for the loss of kidney function.
